COVID-19 Resource Center

In the interest of supporting regulatory professionals addressing the unprecedented public health threat posed by COVID-19, AgencyIQ will be sharing all content concerning the virus and its regulatory implications on this page as the situation evolves. To learn about AgencyIQ and see more of our coverage of FDA, please contact us:

 

COVID-19 Drug and Vaccine Development Tracker​

The pharmaceutical and biopharmaceutical industry is engaged in an unprecedented search for products to potentially treat, cure or prevent COVID-19. AgencyIQ has reviewed ClinicalTrials.gov, company announcements and media reports to provide a detailed landscape of the COVID-19 development pipeline.

Read More »


Latest AgencyIQ COVID-19 Analysis